Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2026-01-04 @ 1:55 PM
Study NCT ID:
NCT03442569
Status:
COMPLETED
Last Update Posted:
2025-07-01
First Post:
2018-02-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Colon Cancer | View |
Keywords: